This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Galapagos Nv, Alfasigma S.p.a.. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: The Innovations of Piet Wigerinck
Introduction
Piet Wigerinck is a notable inventor based in Mechelen, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. With a total of 3 patents to his name, Wigerinck's work has the potential to impact many lives.
Latest Patents
Wigerinck's latest patents focus on salts and pharmaceutical compositions for the treatment of inflammatory disorders. The inventions disclose salts of a Compound 1 that are useful in the prophylaxis and/or treatment of various inflammatory conditions, autoimmune diseases, proliferative diseases, allergies, transplant rejection, and diseases associated with hypersecretion of IL6 or interferons. These innovations aim to address critical health issues related to cartilage homeostasis and congenital cartilage malformations.
Career Highlights
Throughout his career, Wigerinck has worked with prominent companies in the pharmaceutical industry, including Galapagos NV and Alfasigma S.p.A. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Wigerinck has collaborated with several professionals in his field, including Nicolas Luc Sabourault and Ahmad Y Sheikh. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Piet Wigerinck's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His patents reflect a deep understanding of complex medical issues and a dedication to finding effective solutions.